Module now available Long-read sequencing analysis See the research

Infection intelligence

From sequencing file to pathogen report in under five minutes

RipSeq analyzes Sanger and targeted NGS files direct from specimen, whether the sample is negative, pure or poly-microbial, against curated reference databases. Reporting included.

  • NGS and Sanger
  • Runs in the browser
  • Always updated
>  Live demoSynthetic example data
RipSeq
Single
  1. Read file
  2. Analyze trace
  3. Match · RipSeq DB
  4. Report
Illustration only. Not patient data and not a performance claim.

Trusted by leading research institutions worldwide

Over 100 institutions across 25+ countries have published research using our technology.

Scroll
University of BergenMayo ClinicUniversity of UtahARUP LaboratoriesHaukeland University HospitalUniversity of Hawaiʻi at MānoaUT Health Science Center TylerLinköping UniversityYale UniversityMuhimbili UniversityNorwegian Institute of Public HealthUniversity Hospital of North NorwayUniversity of GothenburgNMBU
102
Institutions
100+
Publications
25+
Countries
23
Years of research

The platform

Any sequencer. Any target. One analysis platform.

Platform agnostic

RipSeq analyzes both NGS and Sanger direct-from-specimen sequencing files. Using our novel algorithms, the total time for one analysis is less than five minutes, no matter if the sample is negative, pure or poly-microbial.

Curated databases

RipSeq DB databases hold the most up-to-date references, without the clutter. Databases are filtered and automatically curated to ensure an ID you can rely on.

Cloud SaaS solution

RipSeq is always online and always updated. All you need is an internet browser. Curated reference databases are updated whenever major references are added or changed.

RipSeq products

Negative, mono- and poly-microbial samples

Use any sequencing technology you want. Pick a product to see what it does.

RipSeq NGS product sheet: rapid batch processing of NGS genomics data from clinical samples
NGS

Under five minutes, reporting included

Using our novel algorithms, RipSeq processes your targeted NGS sequence file locally and reduces the information needed to upload by a factor of 1000:1, while still retaining resolution and specificity. After upload, the cloud-based RipSeq analyzes the reads against any of our curated RipSeq DB databases, no matter the target.

  • No lengthy file upload
  • No costly big data file storage
  • Long-read sequencing analysis module now available

From DNA file to report

<5MIN

Completed in under five minutes, reporting included.

Reduced analysis time

90%

Up to 90% less time needed to identify infectious pathogens.

Clinical experience

20+ YEARS

Built by people who run routine diagnostics and research.

RipSeq DB

An ID you can rely on

GenBank contains large numbers of current references. It also has many uninformative or even erroneous references that hinder accurate identification. RipSeq DB filters them out and updates the rest against the latest NCBI taxonomy.

Present in all bacteria and most archaea. Conserved regions make the 16S rRNA gene universal; hypervariable regions make it specific. By far the target used by most RipSeq customers, in both Sanger and NGS.

More about targets

144references returned by a public database
  • Informative reference
  • Outdated taxonomy
  • Uninformative
  • Erroneous

Illustration. Each dot stands for one reference sequence; proportions are not measured values.

Patho-Seq

FDA Breakthrough Device Designation

Patho-Seq is designed for the rapid detection and identification of hundreds of clinically relevant bacteria for a broad list of clinical conditions and sample types, including sepsis from whole blood samples and bacterial meningitis from CSF.

Patho-Seq will not be available for sale until it has received FDA marketing approval.

Designation granted for

  • Sepsis and bacteremia
  • Bacterial meningitis
  • Joint and implant infections
  • Tick-borne bacterial infections

Get started

Start your 14-day free trial

All you need is an internet browser. Whether you have a question, need more information or want to discuss a potential collaboration, our team is here to help.